← back to search

Michael Rink

Marienkrankenhaus Hamburg ·
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Renal cell carcinoma treatment, and Urological Disorders and Treatments.
h-index
59
citations
12,359
works
553
NIH funding
primary concept
email

Recent publications

KDM6A expression loss is frequent in low grade non-invasive urothelial carcinomas of the urinary bladder
Pathologica 2025cited by 1position: middledoi
Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer
European Urology 2024cited by 19position: middledoi
17p13 (<i>TP53</i>) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder Carcinomas
Genes Chromosomes and Cancer 2024cited by 4position: middledoi
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding
British Journal of Urology 2024cited by 0position: middledoi
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
European Urology 2023cited by 604position: middledoi
Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis
Cancers 2023cited by 30position: middledoi
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder
Experimental and Molecular Pathology 2023cited by 8position: middledoi
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder
International Urology and Nephrology 2023cited by 5position: middledoi
Carboplatin Induction Chemotherapy in Clinically Lymph Node–positive Bladder Cancer
European Urology Open Science 2023cited by 5position: middledoi
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder
Human Pathology 2022cited by 23position: middledoi
Does the Identification of a Minimum Number of Cases Correlate With Better Adherence to International Guidelines Regarding the Treatment of Penile Cancer? Survey Results of the European PROspective Penile Cancer Study (E-PROPS)
Frontiers in Oncology 2021cited by 13position: middledoi
Pathogen-induced tissue-resident memory T <sub>H</sub> 17 (T <sub>RM</sub> 17) cells amplify autoimmune kidney disease
Science Immunology 2020cited by 102position: middledoi
Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis
European Urology Oncology 2020cited by 36position: middledoi
Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
European Urology Open Science 2020cited by 23position: middledoi
Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250]
European Urology 2020cited by 16position: middledoi
Primary Ta high grade bladder tumors: Determination of the risk of progression
Urologic Oncology Seminars and Original Investigations 2020cited by 15position: middledoi
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†
European Urology 2019cited by 191position: middledoi
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees
Annals of Oncology 2019cited by 181position: middledoi
Differences in trends in the use of robot‐assisted and open radical cystectomy and changes over time in peri‐operative outcomes among selected centres in North America and Europe: an international multicentre collaboration
British Journal of Urology 2019cited by 81position: middledoi
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases
World Journal of Urology 2019cited by 36position: lastdoi
Peri‐operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score‐weighted European multicentre study
British Journal of Urology 2017cited by 24position: middledoi
Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort
Clinical Genitourinary Cancer 2017cited by 22position: middledoi
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma
Urologic Oncology Seminars and Original Investigations 2017cited by 1position: firstdoi
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
World Journal of Urology 2016cited by 465position: middledoi
Prognostic significance of markers of systemic inflammatory response in patients with non–muscle-invasive bladder cancer
Urologic Oncology Seminars and Original Investigations 2016cited by 75position: middledoi
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy
World Journal of Urology 2016cited by 69position: middledoi
Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node–Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score–Weighted Competing Risks Analysis
European Urology Focus 2016cited by 24position: middledoi
Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder
Urologic Oncology Seminars and Original Investigations 2016cited by 9position: middledoi
Smoking and Bladder Cancer: A Systematic Review of Risk and Outcomes
European Urology Focus 2015cited by 114position: firstdoi
Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy
European Urology 2015cited by 70position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shahrokh F. Shariat · University Hospital in Motol40 papers (2012–2020)Pierre I. Karakiewicz · Université de Montréal27 papers (2012–2020)Évanguelos Xylinas · Université Claude Bernard Lyon 122 papers (2012–2020)Yair Lotan · Cancer Research Center19 papers (2012–2016)Giacomo Novara · University of Padua18 papers (2012–2014)Douglas S. Scherr · NewYork–Presbyterian Hospital18 papers (2012–2014)Felix K.‐H. Chun · Goethe University Frankfurt17 papers (2012–2017) · 15 papers (2012–2021)Hans‐Martin Fritsche · University of Regensburg15 papers (2012–2017)Luis A. Kluth · Goethe University Frankfurt12 papers (2012–2021)Maximilian Burger · University of Regensburg11 papers (2012–2021)Wassim Kassouf · McGill University Health Centre11 papers (2012–2016)Quoc‐Dien Trinh · Brigham and Women's Hospital10 papers (2012–2015)Siamak Daneshmand · The University of Texas at San Antonio10 papers (2012–2015)Harun Fajković · University of Applied Sciences St Pölten9 papers (2012–2016)Vitaly Margulis · Creative Commons9 papers (2012–2016)Atiqullah Aziz · University of Regensburg9 papers (2013–2020)Georgios Gakis · LMU Klinikum8 papers (2013–2023)Arnulf Stenzl · University Children's Hospital Tübingen8 papers (2012–2017)Jens Hansen · Mount Sinai Medical Center8 papers (2012–2015)